InsiderTrades

Form 4 for CRL Charles River Laboratories

Accepted 2021-08-10 00:00:00 ET · period of report 2021-08-06 · accession 0001127602-21-023429 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-08-10 2021-08-06 CRL Kochevar Deborah Turner Dir M - OptEx $164.24 +2,539 9,622 +36% +$417.0K
DM 2021-08-10 2021-08-06 CRL Kochevar Deborah Turner Dir S - Sale+OE $406.43 -3,526 6,096 -37% -$1.43M
D 2021-08-10 2021-08-06 CRL Kochevar Deborah Turner Dir M - OptEx $0.00 -2,539 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-06 M A 2,539 $164.24 9,622 D — —
2 Common Common Stock 2021-08-06 S D 901 $405.73 8,721 D — — (F1) This transaction was executed in multiple trades at prices ranging from $405.18 to $406.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3 Common Common Stock 2021-08-06 S D 2,620 $406.67 6,101 D — — (F2) This transaction was executed in multiple trades at prices ranging from $406.19 to $407.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4 Common Common Stock 2021-08-06 S D 5 $407.29 6,096 D — —
5 Derivative Stock Options (Right to Buy) 2021-08-06 M D 2,539 $0.00 0 D $164.24 · 2021-05-11 to 2030-05-11 2,539 Common Stock